PERBANDINGAN ANGKA BEBAS BATU PADA PASIEN BATU KALIK DENGAN PEMBERIAN DIURESIS DAN TANPA DIURESIS SELAMA ESWL
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: To compare effects of intravenous hydration, both with and without diuretics on the stone free rate of calyceal stones during ESWL. Materials and Methods: We analyzed 22 patients with calyceal stone, primarily treated with Sonolith Vision lithotripter, between June 2008 and October 2008. Patients were divided in 2 groups, the 11 patients in group 1 were injected with 500 ml normal saline for intravenous hydration, and 20 mg of furosemide for diuretic effect during ESWL; the 11 patients in group 2 were used as controls. The same energy settings for the shockwaves in one session were equally applied to all patients during ESWL, with a 1 Hz shockwave frequency, 100% power and 1000 shocks. After 2 weeks the stone free rate and residual fragments were evaluated on the post ESWL KUB and compared with the pre-ESWL KUB. Results: After a single ESWL treatment, the stone-free rate was 81,8% (9 of 11 patients) in group 1 and 63,3% (7 of 11 patients) in group 2. The stone free rates of group 1 was higher than that of group 2, but there was no statistical difference between groups 1 and 2. Conclusion: Intravenous hydration with normal saline with a furosemide injection for diuretic effect during ESWL would be same effective method to facilitate fragmentation and stone free of calyceal stones.
##plugins.themes.bootstrap3.article.details##
Stone free rate, diuresis, calyceal stone, ESWL
Marshall LS, Damien MB. Urinary stone disease. In: Smith’s General Urology. 15th edition. New York: The McGraw-Hill Companies; 2000. p. 291-320.
Margaret L, Pearle S, Yair L. Urinary lithiasis: Etiology, epidemiology, and pathogenesis. In: Campbell-Walsh Urology. 9th edition. Toronto: Sunders; 2007. Chapter 42.
Rochani Sumardi. Guidelines Penatalaksanaan Penyakit Batu Saluran Kemih; 2007. p. 1-45.
Rasweiller JJ. The management of complex renal stones. BJU International 2000; 86: 919-28.
Soebadi DM. Clinical experience with more than 2.000 PCNL cases in a developing country. World Congress of Endourology. Amsterdam: The Nederlands; 2005.
Chew BH. Ureteroscopy and retrograde ureteral access. In: Campbell-Walsh Urology. 9th edition. Toronto: Sunders; 2007. Chapter 45.
Ravi M, Glenn MP. Urinary tract stones. In: Comprehensive Urology. London: Mosby; 2001. p. 313-32.
Bush WH. Radiation dose to patient and personel during ESWL. J. Urol 1987; 138: 716-9.
Michael Grasso. Extracorporeal shockwave lithotripsy. http://www. emedicine.com/med/TOPIC3024. HTM. last update 2008.
Coptcoat MJ. The treatment of 100 consecutive patients with ureteral calculi in British Stone Centre. In: Azm TA, effect of diuresis on extracorporeal shockwave lithotripsy treatment of ureteric calculi. Scand J Urol Nephrol 2001; 36: 209-12.
Muller S. ESWL of ureteral stones: Clinical experience and experimental findings. In: Azm TA, effect of diuresis on extracorporeal shockwave lithotripsy treatment of ureteric calculi. Scand J Urol Nephrol 2001; 36: 209-12.
Azm TA, Higazy H. Effect of diuresis on extracorporeal shockwave lithotripsy treatment of ureteric calculi. Scand J Urol Nephrol 2001; 36: 209-12.
Zomorrdi. Effect of diuretic on stone fragmentation during ESWL. Saudi Arabian Journal of Nephrology and Urology; 2008.
Shin JH, Moon YT. Effects of intravenous fluid and diuretics on stone fragmentation and passage during extracorporeal shock wave lithotripsy (ESWL) of upper ureteral stone. Korean J Urol 2003; 44 (2): 129-33.